Kinh doanh - Marketing
Kinh tế quản lý
Biểu mẫu - Văn bản
Tài chính - Ngân hàng
Công nghệ thông tin
Tiếng anh ngoại ngữ
Kĩ thuật công nghệ
Khoa học tự nhiên
Khoa học xã hội
Văn hóa nghệ thuật
Sức khỏe - Y tế
Văn bản luật
Nông Lâm Ngư
Kỹ năng mềm
Luận văn - Báo cáo
Giải trí - Thư giãn
Tài liệu phổ thông
Văn mẫu
Giới thiệu
Đăng ký
Đăng nhập
Tìm
Danh mục
Kinh doanh - Marketing
Kinh tế quản lý
Biểu mẫu - Văn bản
Tài chính - Ngân hàng
Công nghệ thông tin
Tiếng anh ngoại ngữ
Kĩ thuật công nghệ
Khoa học tự nhiên
Khoa học xã hội
Văn hóa nghệ thuật
Y tế sức khỏe
Văn bản luật
Nông lâm ngư
Kĩ năng mềm
Luận văn - Báo cáo
Giải trí - Thư giãn
Tài liệu phổ thông
Văn mẫu
Thông tin
Điều khoản sử dụng
Quy định bảo mật
Quy chế hoạt động
Chính sách bản quyền
Giới thiệu
Đăng ký
Đăng nhập
0
Trang chủ
Kinh Tế - Quản Lý
Quản lý Nhà nước
Lecture Issues in economics today - Chapter 23: The economics of prescription drugs
Đang chuẩn bị liên kết để tải về tài liệu:
Lecture Issues in economics today - Chapter 23: The economics of prescription drugs
Tùng Minh
103
15
ppt
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
In this chapter you will learn: Apply the concepts of monopoly as well as consumer and producer surplus to the economics of prescription drugs; summarize why most health economists view prescription drugs as relatively inexpensive, even while most noneconomists view them as very expensiv; explain why it is that most health economists do not favor price controls on prescription drugs; identify the consequences of an approval process that is too stringent or too lax. | Chapter 23 The Economics of Prescription Drugs Chapter Outline PROFITEERS OR BENEVOLENT SCIENTISTS MONOPOLY POWER AS IT APPLIES TO DRUGS IMPORTANT QUESTIONS Profiteers or Benevolent Scientists? Spending on drugs accounts for 9% of the more than $1 trillion health care industry The question of advertising Ads for particular drugs These are not unexpected as new cures and remedies are invented. Feel-good political ads These ads are seen as a means to forestall price controls or regulations. Patents A patent is a right granted by government to an inventor to be the exclusive seller on an invention for a limited period of time. Patents motivate innovation with the promise of monopoly profit for a period of time. Orphan Drugs An Orphan Drug is one that treats someone with a disease that afflicts few people. The concern is that there is insufficient potential demand to motivate innovation. For orphan drugs the patent life is extended by several years. The Concern over High Prices Are . | Chapter 23 The Economics of Prescription Drugs Chapter Outline PROFITEERS OR BENEVOLENT SCIENTISTS MONOPOLY POWER AS IT APPLIES TO DRUGS IMPORTANT QUESTIONS Profiteers or Benevolent Scientists? Spending on drugs accounts for 9% of the more than $1 trillion health care industry The question of advertising Ads for particular drugs These are not unexpected as new cures and remedies are invented. Feel-good political ads These ads are seen as a means to forestall price controls or regulations. Patents A patent is a right granted by government to an inventor to be the exclusive seller on an invention for a limited period of time. Patents motivate innovation with the promise of monopoly profit for a period of time. Orphan Drugs An Orphan Drug is one that treats someone with a disease that afflicts few people. The concern is that there is insufficient potential demand to motivate innovation. For orphan drugs the patent life is extended by several years. The Concern over High Prices Are prescription drug prices too high? The answer to many depends on the impact of the disease. For “life or death” drugs price has been an ethical concern. The AIDS “cocktail” (a mix of drugs, used to fight the disease) originally cost $14,000 per patient per year. For “quality of life” drugs it has been less of a concern. Pepcid and Zantac (heartburn medications), Seldane and then Claritan (seasonal allergy medications) cost a great deal but have not raised as much ethical concern. The Impact of Monopoly Power P* Q* MR D MC Q/t P Monopoly vs Perfect Competition MR Pmonop Qmonop D MC=Supply Q/t P PPC QPC A F B C E Under PC CS=PPCAC PS=FPPCC Under Monopoly CS=PmonopAB PS=FPmonopBE DWL=EBC Deadweight Loss Deadweight Loss (DWL) is the loss in social welfare associated with production being too little or too great. In the case of monopoly, production is too little and prices are too high. Important Questions Are prescription drugs expensive necessities or relatively inexpensive godsends? Expensive
TÀI LIỆU LIÊN QUAN
Lecture Issues in economics today - Chapter 24: The economics of crime
Lecture Issues in economics today - Chapter 31: The economics of children
Lecture Issues in economics today - Chapter 1: Economics: The study of opportunity cost
Lecture Issues in economics today - Chapter 23: The economics of prescription drugs
Lecture Issues in economics today - Chapter 2: Supply and demand
Lecture Issues in economics today - Chapter 3: The concept of elasticity and consumer and producer surplus
Lecture Issues in economics today - Chapter 5: Firm production, cost, and revenue
Lecture Issues in economics today - Chapter 6: Perfect competition, monopoly, and economic vs. normal profit
Lecture Issues in economics today - Chapter 7: Every macroeconomic word you have ever heard: gross domestic product, inflation, unemployment, recession and depression
Lecture Issues in economics today - Chapter 9: Federal spending
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.